133 related articles for article (PubMed ID: 8868205)
21. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
22. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
[TBL] [Abstract][Full Text] [Related]
23. Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates.
Gerra G; Garofano L; Bosari S; Pellegrini C; Zaimovic A; Moi G; Bussandri M; Moi A; Brambilla F; Mameli A; Pizzamiglio M; Donnini C
J Neural Transm (Vienna); 2004 May; 111(5):611-21. PubMed ID: 15088154
[TBL] [Abstract][Full Text] [Related]
24. Does naltrexone affect craving in abstinent opioid-dependent patients?
Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
[TBL] [Abstract][Full Text] [Related]
25. Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial.
Tiihonen J; Krupitsky E; Verbitskaya E; Blokhina E; Mamontova O; Föhr J; Tuomola P; Kuoppasalmi K; Kiviniemi V; Zwartau E
Am J Psychiatry; 2012 May; 169(5):531-6. PubMed ID: 22764364
[TBL] [Abstract][Full Text] [Related]
26. Gender differences in hostility of opioid-dependent outpatients: role in early treatment termination.
Petry NM; Bickel WK
Drug Alcohol Depend; 2000 Feb; 58(1-2):27-33. PubMed ID: 10669052
[TBL] [Abstract][Full Text] [Related]
27. Serotonin function in detoxified heroin abusers: prolactin and cortisol responses to fenfluramine challenge.
Gerra G; Fertonani G; Tagliavini P; Zaimovic A; Delsignore R; Maestri D; Avanzini P; Caccavari R; Brambilla F
Psychiatry Res; 1995 Sep; 58(2):153-60. PubMed ID: 8570767
[TBL] [Abstract][Full Text] [Related]
28. A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
McGregor C; Ali R; White JM; Thomas P; Gowing L
Drug Alcohol Depend; 2002 Sep; 68(1):5-14. PubMed ID: 12167548
[TBL] [Abstract][Full Text] [Related]
29. Neuroendocrine correlates of antisocial personality disorder in abstinent heroin-dependent subjects.
Gerra G; Zaimovic A; Moi G; Bussandri M; Delsignore R; Caccavari R; Brambilla F
Addict Biol; 2003 Mar; 8(1):23-32. PubMed ID: 12745412
[TBL] [Abstract][Full Text] [Related]
30. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts.
Handelsman L; Kahn RS; Sturiano C; Rinaldi PJ; Gabriel S; Schmeidler JP; Bernstein DP; Siever L; Cooper TB
Psychiatry Res; 1998 Jul; 80(1):1-12. PubMed ID: 9727959
[TBL] [Abstract][Full Text] [Related]
31. New-onset mania and psychosis following heroin detoxification and naltrexone maintenance.
Sullivan MA; Nunes EV
Am J Addict; 2005; 14(5):486-7. PubMed ID: 16257886
[No Abstract] [Full Text] [Related]
32. A randomized control trial of group counseling in a naltrexone treatment program.
Tucker T; Ritter A; Maher C; Jackson H
J Subst Abuse Treat; 2004 Dec; 27(4):277-88. PubMed ID: 15610829
[TBL] [Abstract][Full Text] [Related]
33. [Depression and aggression. A control group study on the aggression hypothesis in depressive disorders based on the Buss-Durkee Questionnaire].
Wolfersdorf M; Kiefer A
Psychiatr Prax; 1998 Sep; 25(5):240-5. PubMed ID: 9816604
[TBL] [Abstract][Full Text] [Related]
34. Naltrexone in patients with bipolar disorder and alcohol dependence.
Brown ES; Beard L; Dobbs L; Rush AJ
Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
[TBL] [Abstract][Full Text] [Related]
35. Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.
Gerra G; Zaimovic A; Ferri M; Zambelli U; Timpano M; Neri E; Marzocchi GF; Delsignore R; Brambilla F
Biol Psychiatry; 2000 Jan; 47(2):127-36. PubMed ID: 10664829
[TBL] [Abstract][Full Text] [Related]
36. The efficacy of naltrexone in preventing reabuse of heroin after detoxification.
Shufman EN; Porat S; Witztum E; Gandacu D; Bar-Hamburger R; Ginath Y
Biol Psychiatry; 1994 Jun; 35(12):935-45. PubMed ID: 8080893
[TBL] [Abstract][Full Text] [Related]
37. Trait aggression and hostility in recovered alcoholics.
Ziherl S; Cebasek Travnik Z; Kores Plesnicar B; Tomori M; Zalar B
Eur Addict Res; 2007; 13(2):89-93. PubMed ID: 17356280
[TBL] [Abstract][Full Text] [Related]
38. Relationship of personality traits and drug of choice by cocaine addicts and heroin addicts.
Gerra G; Bertacca S; Zaimovic A; Pirani M; Branchi B; Ferri M
Subst Use Misuse; 2008; 43(3-4):317-30. PubMed ID: 18365934
[TBL] [Abstract][Full Text] [Related]
39. Naltrexone: report of lack of hepatotoxicity in acute viral hepatitis, with a review of the literature.
Brewer C; Wong VS
Addict Biol; 2004 Mar; 9(1):81-7. PubMed ID: 15203443
[TBL] [Abstract][Full Text] [Related]
40. Effects of incentives for naltrexone adherence on opiate abstinence in heroin-dependent adults.
Jarvis BP; Holtyn AF; DeFulio A; Dunn KE; Everly JJ; Leoutsakos JS; Umbricht A; Fingerhood M; Bigelow GE; Silverman K
Addiction; 2017 May; 112(5):830-837. PubMed ID: 27936293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
